Can Repurposed Drugs Reverse Established Fibrosis? Evidence from Experimental and Clinical Studies
Year: 2026
Type: preprint
Abstract: Can repurposed drugs reverse established fibrosis? This narrative mini-review examines experimental and clinical evidence on five drugs: metformin, simvastatin, losartan, pentoxifylline, and colchicine. It asks whether each study shows a lower matrix burden at the end of treatment, a decline from the burden present when treatment began, or a reduction that persists after drug clearance. An evidence table summarises 12 comparisons from 10 primary studies, documenting treatment timing, evidence of fibrosis at baseline, comparators, outcomes, and follow-up. Delayed metformin and simvastatin reduced final lung collagen burden in experimental models, while the clinical studies showed mixed or inconclusive histological results. None of the reviewed comparisons established that a reduction persisted after drug clearance. The review outlines how pretreatment measurements, concurrent controls, and post-treatment follow-up can help determine whether an intervention slows further matrix accumulation or produces durable regression of established fibrosis.
Author: Gondim Moreira, Christiano
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7234256519
